Capecitabine and Aprepitant drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Capecitabine and Aprepitant. Common interactions include alopecia among females and neutrophil count decreased among males.
The phase IV clinical study analyzes what interactions people who take Capecitabine and Aprepitant have. It is created by eHealthMe based on reports of 187 people who take Capecitabine and Aprepitant from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
187 people who take Capecitabine and Aprepitant together, and have interactions are studied.
What is Capecitabine?
Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 48,686 Capecitabine users for its effectiveness, alternative drugs and more.
What is Aprepitant?
Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 4,992 Aprepitant users for its effectiveness, alternative drugs and more.
Number of Capecitabine and Aprepitant reports submitted per year:
Capecitabine and Aprepitant drug interactions by gender *:
Capecitabine and Aprepitant drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Capecitabine and Aprepitant?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Capecitabine (48,686 reports)
- Aprepitant (4,992 reports)
Browse all drug interactions of Capecitabine and Aprepitant:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Capecitabine side effects:
- Diarrhea: 7,607 reports
- Death: 4,240 reports
- Nausea and vomiting: 3,792 reports
- Fatigue (feeling of tiredness): 3,733 reports
- Thrombocytopenia (decrease of platelets in blood): 2,561 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2,375 reports
Browse all side effects of Capecitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Aprepitant side effects:
- Fatigue (feeling of tiredness): 607 reports
- Hair loss: 441 reports
- Diarrhea: 440 reports
- Fever: 420 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 373 reports
- Nausea and vomiting: 344 reports
- Rashes (redness): 341 reports
- Breathing difficulty: 330 reports
Browse all side effects of Aprepitant:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Capecitabine interactions:
- Capecitabine and Oxaliplatin: 9,975 reports
- Capecitabine and Fluorouracil: 3,100 reports
- Capecitabine and Cisplatin: 3,022 reports
- Capecitabine and Docetaxel: 2,681 reports
- Capecitabine and Paclitaxel: 2,453 reports
- Capecitabine and Ondansetron: 1,886 reports
- Capecitabine and Omeprazole: 1,697 reports
- Capecitabine and Letrozole: 1,491 reports
- Capecitabine and Cyclophosphamide: 1,259 reports
- Capecitabine and Aspirin: 1,250 reports
Browse all interactions between Capecitabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Aprepitant interactions:
- Aprepitant and Ondansetron: 1,950 reports
- Aprepitant and Cisplatin: 1,214 reports
- Aprepitant and Clopra: 1,203 reports
- Aprepitant and Metoclopramide: 1,202 reports
- Aprepitant and Dexamethasone: 987 reports
- Aprepitant and Cyclophosphamide: 861 reports
- Aprepitant and Palonosetron: 840 reports
- Aprepitant and Carboplatin: 781 reports
- Aprepitant and Fluorouracil: 695 reports
- Aprepitant and Pantoprazole: 670 reports
Browse all interactions between Aprepitant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on capecitabine and aprepitant (the active ingredients of Capecitabine and Aprepitant, respectively), and Capecitabine and Aprepitant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Capecitabine and Aprepitant.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Divalproex and Electrocardiogram Qrs Complex Prolonged - 10 seconds ago
- Paracetamol and Xylocaine Dental drug interaction - 28 seconds ago
- Metadate Cd and Dehydration - 40 seconds ago
- Dermatitis Exfoliative Aggravated and Atrial Fibrillation/Flutter - 43 seconds ago
- Tramadol Hydrochloride and Cervical Vertebral Fracture - 48 seconds ago
- Glucotrol and Ortho Tri-Cyclen drug interaction - 50 seconds ago
- Norditropin and Operative Haemorrhage - 52 seconds ago
- Capitrol and Asa drug interaction - 52 seconds ago
- Sodium Nitroprusside and Hypermagnesaemia - 55 seconds ago
- Ketoconazole and Cancer - Throat Or Larynx - a minute ago